MTP 076 Clinical questions to be addressed: What are the new thoughts in the management of steroid-induced osteoporosis? What are the new therapeutics in the treatment of osteoporosis? How long can and should patients be maintained on bisphosphonate therapy? What are the secondary causes of osteoporosis, and who should be evaluated for secondary causes? Does osteonecrosis of the jaw occur in patients with osteoporosis who are being treated with bisphosphonates? What are the risk factors? What are the guidelines for evaluating men for osteoporosis? What are the treatment recommendations? What is the evidence supporting the approach to deciding on treatment options?